Kuoyuan Cheng
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Kuoyuan Cheng has a total of 192 co-authors. Here are the top co-authors by number of shared publications:
- Eytan Ruppin
Cancer Data Science Laboratory, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA
83 shared publications - Alejandro Schaffer
Cancer Data Science Laboratory, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, USA
74 shared publications - Lipika R. Pal
National Cancer Institute 1 Cancer Data Science Laboratory, Center for Cancer Research National Institutes of Health, Bethesda, Maryland
57 shared publications - Yardena Samuels
Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel
56 shared publications - Ansuman T. Satpathy
Department of Pathology, School of Medicine, Stanford University, Palo Alto, USA
55 shared publications - Chen Weller
Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel
55 shared publications
Latest Publications
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Table S2 from Chromosome 7 Gain Compensates for Chromosome 10 Loss in Glioma
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessTable S2 from Chromosome 7 Gain Compensates for Chromosome 10 Loss in Glioma
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Material from Chromosome 7 Gain Compensates for Chromosome 10 Loss in Glioma
Supplementary Notes, Supplementary Figures, and Supplementary Table Legends
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Material from Chromosome 7 Gain Compensates for Chromosome 10 Loss in Glioma
Supplementary Notes, Supplementary Figures, and Supplementary Table Legends
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 1 from Temporal Genomic Analysis of Homogeneous Tumor Models Reveals Key Regulators of Immune Evasion in Melanoma
Clinical data and characterization of the single-cell clones.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 1 from Temporal Genomic Analysis of Homogeneous Tumor Models Reveals Key Regulators of Immune Evasion in Melanoma
Clinical data and characterization of the single-cell clones.
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table 10 from Temporal Genomic Analysis of Homogeneous Tumor Models Reveals Key Regulators of Immune Evasion in Melanoma
List of antibodies used for IHC staining of human samples.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 10 from Temporal Genomic Analysis of Homogeneous Tumor Models Reveals Key Regulators of Immune Evasion in Melanoma
List of antibodies used for IHC staining of human samples.
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 13 from Temporal Genomic Analysis of Homogeneous Tumor Models Reveals Key Regulators of Immune Evasion in Melanoma
ScRNA-seq characterization of Mif KO tumor clones.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 13 from Temporal Genomic Analysis of Homogeneous Tumor Models Reveals Key Regulators of Immune Evasion in Melanoma
ScRNA-seq characterization of Mif KO tumor clones.
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Tables- legends from Temporal Genomic Analysis of Homogeneous Tumor Models Reveals Key Regulators of Immune Evasion in Melanoma
Legends for the supplementary tables 1-10.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Tables- legends from Temporal Genomic Analysis of Homogeneous Tumor Models Reveals Key Regulators of Immune Evasion in Melanoma
Legends for the supplementary tables 1-10.
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table 3 from Temporal Genomic Analysis of Homogeneous Tumor Models Reveals Key Regulators of Immune Evasion in Melanoma
Pathway enrichment in samples at day 0 post-inoculation.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 3 from Temporal Genomic Analysis of Homogeneous Tumor Models Reveals Key Regulators of Immune Evasion in Melanoma
Pathway enrichment in samples at day 0 post-inoculation.
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 7 from Temporal Genomic Analysis of Homogeneous Tumor Models Reveals Key Regulators of Immune Evasion in Melanoma
Rejection and non-rejection gene sets identified in the scRNA sequencing analysis can stratify patients with high/low ITH and hot/cold tumor annotations.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 7 from Temporal Genomic Analysis of Homogeneous Tumor Models Reveals Key Regulators of Immune Evasion in Melanoma
Rejection and non-rejection gene sets identified in the scRNA sequencing analysis can stratify patients with high/low ITH and hot/cold tumor annotations.
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table 4 from Temporal Genomic Analysis of Homogeneous Tumor Models Reveals Key Regulators of Immune Evasion in Melanoma
Pathway enrichment in samples at days 6, 10, 16, and 20 post-inoculation.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 4 from Temporal Genomic Analysis of Homogeneous Tumor Models Reveals Key Regulators of Immune Evasion in Melanoma
Pathway enrichment in samples at days 6, 10, 16, and 20 post-inoculation.
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Table S6 from Chromosome 7 Gain Compensates for Chromosome 10 Loss in Glioma
Table S6 from Chromosome 7 Gain Compensates for Chromosome 10 Loss in Glioma
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessTable S6 from Chromosome 7 Gain Compensates for Chromosome 10 Loss in Glioma
Table S6 from Chromosome 7 Gain Compensates for Chromosome 10 Loss in Glioma